These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8383627

  • 21. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma].
    Schneider J, Martin M, Erasun F, Matia JC, Rodriguez-Escudero FJ.
    Zentralbl Gynakol; 1988; 110(22):1443-8. PubMed ID: 3223119
    [Abstract] [Full Text] [Related]

  • 22. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
    Gadducci A, Carnino F, Chiara S, Brunetti I, Tanganelli L, Romanini A, Bruzzone M, Conte PF.
    Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
    [Abstract] [Full Text] [Related]

  • 23. Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.
    Nauta MM, Boven E, Schlüper HM, Erkelens CA, Pinedo HM.
    Br J Cancer; 1986 Aug; 54(2):331-5. PubMed ID: 3017398
    [No Abstract] [Full Text] [Related]

  • 24. Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma.
    Skírnisdóttir I, Lindborg K, Sorbe B.
    Oncol Rep; 2007 Nov; 18(5):1249-56. PubMed ID: 17914581
    [Abstract] [Full Text] [Related]

  • 25. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D, Fountzilas G, Aravantinos G, Kalofonos C, Efstathiou H, Farmakis D, Skarlos D, Pavlidis N, Economopoulos T, Dimopoulos MA.
    Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
    [Abstract] [Full Text] [Related]

  • 26. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C, Greggi S, Tambaro R, Losito S, Iodice F, Di Maio M, Ferrari E, Falanga M, Formato R, Iaffaioli VR, Pignata S.
    Anticancer Res; 2005 Aug; 25(5):3501-5. PubMed ID: 16101169
    [Abstract] [Full Text] [Related]

  • 27. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T, Adolph A, Krepart GV, Lotocki R, Heywood MS.
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [Abstract] [Full Text] [Related]

  • 28. [Methods of optimizing and objective criteria for evaluating the efficacy of chemo-surgical treatment of malignant epithelial tumors of the ovaries].
    Nechaeva ID, Vinokurov VL, Iurkova LE, Kotova DG, Aĭnbinder NM, Livshits MA, Zel'dovich DR, Mitrokhina MV.
    Vopr Onkol; 1990 May; 36(8):992-5. PubMed ID: 2171227
    [Abstract] [Full Text] [Related]

  • 29. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG, Rubin SC, Muggia F, McGuire WP, Gynecologic Oncology Group.
    J Clin Oncol; 2008 Jan 01; 26(1):83-9. PubMed ID: 18025437
    [Abstract] [Full Text] [Related]

  • 30. Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group study.
    Markman M, Blessing JA, Major F, Manetta A.
    Gynecol Oncol; 1993 Aug 01; 50(2):191-5. PubMed ID: 8375734
    [Abstract] [Full Text] [Related]

  • 31. Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.
    Bamias A, Bamia C, Zagouri F, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A, Dimopoulos MA.
    Oncology; 2013 Aug 01; 84(3):158-65. PubMed ID: 23296063
    [Abstract] [Full Text] [Related]

  • 32. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
    Liljefors M, Nilsson B, Hjelm Skog AL, Ragnhammar P, Mellstedt H, Frödin JE.
    Int J Cancer; 2003 Jul 10; 105(5):717-23. PubMed ID: 12740924
    [Abstract] [Full Text] [Related]

  • 33. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
    Yahata H, Hirakawa T, Fujita T, Ariyoshi K, Sonoda K, Amada S, Kobayashi H, Nakano H.
    Int J Clin Oncol; 2004 Aug 10; 9(4):317-21. PubMed ID: 15375709
    [Abstract] [Full Text] [Related]

  • 34. The management of ovarian carcinoma--a review of 420 cases.
    Barr W, Cowell AC, Chatfield WR.
    Scott Med J; 1970 Jul 10; 15(7):250-6. PubMed ID: 5427786
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy of adjuvant carboplatin-epirubicin chemotherapy in advanced ovarian cancer after radical surgery.
    Pickel H, Petru E, Lahousen M, Stettner H, Lehnert M.
    Oncology; 1989 Jul 10; 46(4):222-5. PubMed ID: 2662087
    [Abstract] [Full Text] [Related]

  • 36. Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma.
    Gadducci A, Viacava P, Cosio S, Fanelli G, Fanucchi A, Cecchetti D, Cristofani R, Genazzani AR.
    Anticancer Res; 2003 Jul 10; 23(1B):549-56. PubMed ID: 12680144
    [Abstract] [Full Text] [Related]

  • 37. Re: Mucinous ovarian cancer.
    Omura GA.
    Gynecol Oncol; 2005 Dec 10; 99(3):789; author reply 789-90. PubMed ID: 16125757
    [No Abstract] [Full Text] [Related]

  • 38. [Ovarian mucinous carcinoma in a 12-year old girl].
    Juszkiewicz P, Niedzielski A.
    Ginekol Pol; 1993 Jun 10; 64(6):314-6. PubMed ID: 8397149
    [Abstract] [Full Text] [Related]

  • 39. Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study.
    Grem J, O'Dwyer P, Elson P, Simon N, Trump D, Frontiera M, Falkson G, Vogl S.
    J Clin Oncol; 1991 Oct 10; 9(10):1793-800. PubMed ID: 1919629
    [Abstract] [Full Text] [Related]

  • 40. Augmented natural killer activity in ovarian cancer patients treated with cimetidine.
    Kikuchi Y, Oomori K, Kizawa I, Kato K.
    Eur J Cancer Clin Oncol; 1986 Sep 10; 22(9):1037-43. PubMed ID: 3780810
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.